The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane

Hyunbum Jang, Iris Nira Smith, Charis Eng*, Ruth Nussinov*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Tumor suppressor PTEN, the second most highly mutated protein in cancer, dephosphorylates signaling lipid PIP3 produced by PI3Ks. Excess PIP3 promotes cell proliferation. The mechanism at the membrane of this pivotal phosphatase is unknown hindering drug discovery. Exploiting explicit solvent simulations, we tracked full-length PTEN trafficking from the cytosol to the membrane. We observed its interaction with membranes composed of zwitterionic phosphatidylcholine, anionic phosphatidylserine, and phosphoinositides, including signaling lipids PIP2 and PIP3. We tracked its moving away from the zwitterionic and getting absorbed onto anionic membrane that harbors PIP3. We followed it localizing on microdomains enriched in signaling lipids, as PI3K does, and observed PIP3 allosterically unfolding the N-terminal PIP2 binding domain, positioning it favorably for the polybasic motif interaction with PIP2. Finally, we determined PTEN catalytic action at the membrane, all in line with experimental observations, deciphering the mechanisms of how PTEN anchors to the membrane and restrains cancer.

Original languageEnglish
Article number102438
JournaliScience
Volume24
Issue number5
DOIs
StatePublished - 21 May 2021

Funding

FundersFunder number
National Institutes of HealthHHSN26120080001E
U.S. Department of Health and Human Services
National Cancer Institute
Ambrose Monell Foundation
Government of South Australia

    Keywords

    • Cancer
    • In Silico Biology
    • Structural Biology

    Fingerprint

    Dive into the research topics of 'The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane'. Together they form a unique fingerprint.

    Cite this